| Initial public issue of upto 53,18,000 equity shares of face value of
Rs. 10/- each ("Equity Shares") of Vardaan Biotech Limited ("VBL" or the "Company") at an issue price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) for cash, aggregating up to Rs. [*] crores ("Public Issue") comprising a fresh issue of upto 48,18,000 equity shares aggregating to Rs. [*] crores (the "Fresh Issue") and an offer for sale of upto 5,00,000 equity shares by Lokendra Singh Rajput; ("The Selling Shareholders") aggregating to [*] equity shares by the selling shareholders ("Offer for Sale") aggregating to Rs. [*] crores out of which 5,32,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public isssue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the "Net Issue". The public isssue and net issue will constitute [*]% and [*]% respectively of the post-issue paid-up equity share capital of the company.
The price band and the minimum bid lot will be decided by the company.
|